Elevated Expression of LYPD3 Is Associated with Lung Adenocarcinoma Carcinogenesis and Poor Prognosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elevated Expression of LYPD3 Is Associated with Lung Adenocarcinoma Carcinogenesis and Poor Prognosis

Published:2020-04-01 Issue:4 Volume:39 Page:522-532
ISSN:1044-5498
Container-title:DNA and Cell Biology
language:en
Short-container-title:DNA and Cell Biology

Author:

Hu Ping¹,Huang Ying²,Gao Yuanyuan²,Yan Hui³,Li Xiaoge⁴,Zhang Jiao¹,Wang Yan¹,Zhao Yanjiao²

Affiliation:

1. Department of Medical Oncology, General Hospital of Ningxia Medical University, Yinchuan, P.R. China.

2. The Third Department of Medicine Oncology, General Hospital of Ningxia Medical University, Yinchuan, P.R. China.

3. The Second Department of Medicine Oncology, General Hospital of Ningxia Medical University, Yinchuan, P.R. China.

4. Department of Paediatrics, Tianjin Jinnan Xiaozhan Hospital, Tianjin, P.R. China.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Genetics,Molecular Biology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/dna.2019.5116

Reference37 articles.

1. Genome-wide copy number variation pattern analysis and a classification signature for non-small cell lung cancer

2. Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer

3. FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First-Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non-Small Cell Lung Cancer

4. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

5. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overexpression of ESYT3 improves radioimmune responses through activating cGAS-STING pathway in lung adenocarcinoma;Experimental Hematology & Oncology;2024-08-05

2. Development of a prognostic model for lung adenocarcinoma polarity‐related genes and analysis of immune landscape;Biotechnology and Applied Biochemistry;2024-03-12

3. Comprehensive analysis of exosome gene LYPD3 and prognosis/immune cell infiltration in lung cancer;Translational Cancer Research;2024-03

4. LY6/PLAUR domain containing 3 (LYPD3) maintains melanoma cell stemness and mediates an immunosuppressive microenvironment;Biology Direct;2023-11-03

5. Constructing an APOBEC-related gene signature with predictive value in the overall survival and therapeutic sensitivity in lung adenocarcinoma;Heliyon;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3